ID   NEK7_HUMAN              Reviewed;         302 AA.
AC   Q8TDX7; A6NGT8;
DT   03-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   15-MAR-2017, entry version 139.
DE   RecName: Full=Serine/threonine-protein kinase Nek7;
DE            EC=2.7.11.1;
DE   AltName: Full=Never in mitosis A-related kinase 7;
DE            Short=NimA-related protein kinase 7;
GN   Name=NEK7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=11701951;
RA   Kimura M., Okano Y.;
RT   "Identification and assignment of the human NIMA-related protein
RT   kinase 7 gene (NEK7) to human chromosome 1q31.3.";
RL   Cytogenet. Cell Genet. 94:33-38(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Pancreatic islet;
RA   Melton D., Meadows A., Clifton S., Hillier L., Marra M., Pape D.,
RA   Wylie T., Martin J., Blistain A., Schmitt A., Theising B., Ritter E.,
RA   Ronko I., Bennett J., Cardenas M., Gibbons M., McCann R., Cole R.,
RA   Tsagareishvili R., Williams T., Jackson Y., Bowers Y.;
RT   "WashU-Harvard pancreas EST project.";
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   PHOSPHORYLATION AT SER-195.
RX   PubMed=12840024; DOI=10.1074/jbc.M303663200;
RA   Belham C., Roig J., Caldwell J.A., Aoyama Y., Kemp B.E., Comb M.,
RA   Avruch J.;
RT   "A mitotic cascade of NIMA family kinases. Nercc1/Nek9 activates the
RT   Nek6 and Nek7 kinases.";
RL   J. Biol. Chem. 278:34897-34909(2003).
RN   [6]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17101132; DOI=10.1016/j.febslet.2006.10.069;
RA   Yissachar N., Salem H., Tennenbaum T., Motro B.;
RT   "Nek7 kinase is enriched at the centrosome, and is required for proper
RT   spindle assembly and mitotic progression.";
RL   FEBS Lett. 580:6489-6495(2006).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17586473; DOI=10.1016/j.bbrc.2007.05.206;
RA   Kim S., Lee K., Rhee K.;
RT   "NEK7 is a centrosomal kinase critical for microtubule nucleation.";
RL   Biochem. Biophys. Res. Commun. 360:56-62(2007).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH NEK9.
RX   PubMed=19414596; DOI=10.1128/MCB.01867-08;
RA   O'Regan L., Fry A.M.;
RT   "The Nek6 and Nek7 protein kinases are required for robust mitotic
RT   spindle formation and cytokinesis.";
RL   Mol. Cell. Biol. 29:3975-3990(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   SUBUNIT.
RX   PubMed=21320329; DOI=10.1186/1472-6807-11-12;
RA   Meirelles G.V., Silva J.C., Mendonca Yde A., Ramos C.H.,
RA   Torriani I.L., Kobarg J.;
RT   "Human Nek6 is a monomeric mostly globular kinase with an unfolded
RT   short N-terminal domain.";
RL   BMC Struct. Biol. 11:12-12(2011).
RN   [12]
RP   REVIEW.
RX   PubMed=17727698; DOI=10.1186/1747-1028-2-25;
RA   O'regan L., Blot J., Fry A.M.;
RT   "Mitotic regulation by NIMA-related kinases.";
RL   Cell Div. 2:25-25(2007).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS), DOMAIN, ENZYME REGULATION, AND
RP   MUTAGENESIS OF TYR-28; LEU-31; ASN-33 AND TYR-97.
RX   PubMed=19941817; DOI=10.1016/j.molcel.2009.09.038;
RA   Richards M.W., O'Regan L., Mas-Droux C., Blot J.M., Cheung J.,
RA   Hoelder S., Fry A.M., Bayliss R.;
RT   "An autoinhibitory tyrosine motif in the cell-cycle-regulated Nek7
RT   kinase is released through binding of Nek9.";
RL   Mol. Cell 36:560-570(2009).
RN   [16]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLY-35 AND MET-275.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Protein kinase which plays an important role in mitotic
CC       cell cycle progression. Required for microtubule nucleation
CC       activity of the centrosome, robust mitotic spindle formation and
CC       cytokinesis. Phosphorylates RPS6KB1. {ECO:0000269|PubMed:17101132,
CC       ECO:0000269|PubMed:17586473, ECO:0000269|PubMed:19414596}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ENZYME REGULATION: Binding to NEK9 stimulates its activity by
CC       releasing the autoinhibitory function of Tyr-97.
CC       {ECO:0000269|PubMed:19941817}.
CC   -!- SUBUNIT: Monomer. Interacts with NEK9.
CC       {ECO:0000269|PubMed:19414596, ECO:0000269|PubMed:21320329}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Cytoplasm, cytoskeleton,
CC       spindle pole. Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome. Note=Present at centrosome throughout the cell
CC       cycle. Also detected at spindle midzone of the anaphase cells and
CC       eventually concentrates at the midbody.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TDX7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TDX7-2; Sequence=VSP_041243, VSP_041244;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in lung, muscle, testis,
CC       brain, heart, liver, leukocyte and spleen. Lower expression in
CC       ovary, prostate and kidney. No expression seen in small intestine.
CC       {ECO:0000269|PubMed:11701951}.
CC   -!- DOMAIN: Displays an autoinhibited conformation: Tyr-97 side chain
CC       points into the active site, interacts with the activation loop,
CC       and blocks the alphaC helix. The autoinhibitory conformation is
CC       released upon binding with NEK9. {ECO:0000269|PubMed:19941817}.
CC   -!- DOMAIN: The NTE (N-terminal extension) motif is a structural
CC       component of the catalytic domain and thus contributes to
CC       activity. {ECO:0000269|PubMed:19941817}.
CC   -!- PTM: Phosphorylation at Ser-195 required for its activation.
CC       {ECO:0000269|PubMed:12840024}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. NEK Ser/Thr
CC       protein kinase family. NIMA subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB062450; BAB85632.1; -; mRNA.
DR   EMBL; CK819069; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC093419; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093561; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471067; EAW91294.1; -; Genomic_DNA.
DR   CCDS; CCDS1394.1; -. [Q8TDX7-1]
DR   RefSeq; NP_598001.1; NM_133494.2. [Q8TDX7-1]
DR   UniGene; Hs.24119; -.
DR   UniGene; Hs.745083; -.
DR   PDB; 2WQM; X-ray; 2.10 A; A=1-302.
DR   PDB; 2WQN; X-ray; 2.30 A; A=1-302.
DR   PDB; 5DE2; X-ray; 2.78 A; A/B=1-302.
DR   PDBsum; 2WQM; -.
DR   PDBsum; 2WQN; -.
DR   PDBsum; 5DE2; -.
DR   ProteinModelPortal; Q8TDX7; -.
DR   SMR; Q8TDX7; -.
DR   BioGrid; 126636; 18.
DR   DIP; DIP-50780N; -.
DR   IntAct; Q8TDX7; 12.
DR   STRING; 9606.ENSP00000356355; -.
DR   BindingDB; Q8TDX7; -.
DR   ChEMBL; CHEMBL4849; -.
DR   GuidetoPHARMACOLOGY; 2122; -.
DR   TCDB; 1.I.1.1.3; the nuclear pore complex (npc) family.
DR   iPTMnet; Q8TDX7; -.
DR   PhosphoSitePlus; Q8TDX7; -.
DR   BioMuta; NEK7; -.
DR   DMDM; 37537965; -.
DR   EPD; Q8TDX7; -.
DR   MaxQB; Q8TDX7; -.
DR   PaxDb; Q8TDX7; -.
DR   PeptideAtlas; Q8TDX7; -.
DR   PRIDE; Q8TDX7; -.
DR   DNASU; 140609; -.
DR   Ensembl; ENST00000367383; ENSP00000356353; ENSG00000151414. [Q8TDX7-2]
DR   Ensembl; ENST00000367385; ENSP00000356355; ENSG00000151414. [Q8TDX7-1]
DR   Ensembl; ENST00000538004; ENSP00000444621; ENSG00000151414. [Q8TDX7-1]
DR   GeneID; 140609; -.
DR   KEGG; hsa:140609; -.
DR   UCSC; uc001gun.5; human. [Q8TDX7-1]
DR   CTD; 140609; -.
DR   DisGeNET; 140609; -.
DR   GeneCards; NEK7; -.
DR   HGNC; HGNC:13386; NEK7.
DR   HPA; HPA015520; -.
DR   HPA; HPA018193; -.
DR   MIM; 606848; gene.
DR   neXtProt; NX_Q8TDX7; -.
DR   OpenTargets; ENSG00000151414; -.
DR   PharmGKB; PA31551; -.
DR   eggNOG; KOG0591; Eukaryota.
DR   eggNOG; ENOG410XNQP; LUCA.
DR   GeneTree; ENSGT00760000118997; -.
DR   HOGENOM; HOG000233029; -.
DR   HOVERGEN; HBG105886; -.
DR   InParanoid; Q8TDX7; -.
DR   KO; K20876; -.
DR   OMA; QLVNICI; -.
DR   OrthoDB; EOG091G0AER; -.
DR   PhylomeDB; Q8TDX7; -.
DR   TreeFam; TF105135; -.
DR   Reactome; R-HSA-2980767; Activation of NIMA Kinases NEK9, NEK6, NEK7.
DR   Reactome; R-HSA-3301854; Nuclear Pore Complex (NPC) Disassembly.
DR   SignaLink; Q8TDX7; -.
DR   SIGNOR; Q8TDX7; -.
DR   ChiTaRS; NEK7; human.
DR   EvolutionaryTrace; Q8TDX7; -.
DR   GenomeRNAi; 140609; -.
DR   PRO; PR:Q8TDX7; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000151414; -.
DR   CleanEx; HS_NEK7; -.
DR   ExpressionAtlas; Q8TDX7; baseline and differential.
DR   Genevisible; Q8TDX7; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000922; C:spindle pole; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0000910; P:cytokinesis; TAS:UniProtKB.
DR   GO; GO:0051973; P:positive regulation of telomerase activity; IMP:BHF-UCL.
DR   GO; GO:1904355; P:positive regulation of telomere capping; IMP:BHF-UCL.
DR   GO; GO:0032212; P:positive regulation of telomere maintenance via telomerase; IMP:BHF-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0007346; P:regulation of mitotic cell cycle; TAS:UniProtKB.
DR   GO; GO:0051225; P:spindle assembly; TAS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Kinase; Magnesium;
KW   Metal-binding; Microtubule; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    302       Serine/threonine-protein kinase Nek7.
FT                                /FTId=PRO_0000086430.
FT   DOMAIN       34    299       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      40     48       ATP.
FT   REGION       20     33       NTE motif.
FT   ACT_SITE    161    161       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      63     63       ATP.
FT   SITE         97     97       Autoinhibitory.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES       5      5       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     195    195       Phosphoserine; by NEK9.
FT                                {ECO:0000269|PubMed:12840024}.
FT   VAR_SEQ      67    119       IFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL
FT                                NIVLELADAGDL -> VCLLPVWERRVCALNACYFLEIIKG
FT                                SESLQYMATLTNLFENLPVSHHGSFAKK (in isoform
FT                                2). {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_041243.
FT   VAR_SEQ     120    302       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_041244.
FT   VARIANT      35     35       R -> G (in dbSNP:rs55833332).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040924.
FT   VARIANT     275    275       I -> M (in an ovarian serous carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040925.
FT   MUTAGEN      28     28       Y->A: Significant decrease in catalytic
FT                                activity; when associated with A-31.
FT                                {ECO:0000269|PubMed:19941817}.
FT   MUTAGEN      31     31       L->A: Significant decrease in catalytic
FT                                activity; when associated with A-28.
FT                                {ECO:0000269|PubMed:19941817}.
FT   MUTAGEN      33     33       N->D: Significant decrease in catalytic
FT                                activity. {ECO:0000269|PubMed:19941817}.
FT   MUTAGEN      97     97       Y->A: 5-fold increase in catalytic
FT                                activity. {ECO:0000269|PubMed:19941817}.
FT   MUTAGEN      97     97       Y->F,L: Moderate increase in catalytic
FT                                activity. {ECO:0000269|PubMed:19941817}.
FT   HELIX        24     26       {ECO:0000244|PDB:2WQM}.
FT   HELIX        31     33       {ECO:0000244|PDB:2WQM}.
FT   STRAND       34     41       {ECO:0000244|PDB:2WQM}.
FT   STRAND       47     53       {ECO:0000244|PDB:2WQM}.
FT   TURN         54     56       {ECO:0000244|PDB:2WQM}.
FT   STRAND       59     65       {ECO:0000244|PDB:2WQM}.
FT   TURN         67     70       {ECO:0000244|PDB:2WQN}.
FT   HELIX        73     87       {ECO:0000244|PDB:2WQM}.
FT   STRAND       97    103       {ECO:0000244|PDB:2WQM}.
FT   STRAND      106    112       {ECO:0000244|PDB:2WQM}.
FT   HELIX       119    128       {ECO:0000244|PDB:2WQM}.
FT   HELIX       135    154       {ECO:0000244|PDB:2WQM}.
FT   HELIX       164    166       {ECO:0000244|PDB:2WQM}.
FT   STRAND      167    169       {ECO:0000244|PDB:2WQM}.
FT   STRAND      175    177       {ECO:0000244|PDB:2WQM}.
FT   HELIX       205    208       {ECO:0000244|PDB:2WQM}.
FT   HELIX       215    231       {ECO:0000244|PDB:2WQM}.
FT   HELIX       243    251       {ECO:0000244|PDB:2WQM}.
FT   TURN        260    262       {ECO:0000244|PDB:2WQM}.
FT   HELIX       265    274       {ECO:0000244|PDB:2WQM}.
FT   HELIX       279    281       {ECO:0000244|PDB:2WQM}.
FT   HELIX       285    299       {ECO:0000244|PDB:2WQM}.
SQ   SEQUENCE   302 AA;  34551 MW;  C1FC990B34D94D4C CRC64;
     MDEQSQGMQG PPVPQFQPQK ALRPDMGYNT LANFRIEKKI GRGQFSEVYR AACLLDGVPV
     ALKKVQIFDL MDAKARADCI KEIDLLKQLN HPNVIKYYAS FIEDNELNIV LELADAGDLS
     RMIKHFKKQK RLIPERTVWK YFVQLCSALE HMHSRRVMHR DIKPANVFIT ATGVVKLGDL
     GLGRFFSSKT TAAHSLVGTP YYMSPERIHE NGYNFKSDIW SLGCLLYEMA ALQSPFYGDK
     MNLYSLCKKI EQCDYPPLPS DHYSEELRQL VNMCINPDPE KRPDVTYVYD VAKRMHACTA
     SS
//
